Prostaglandin E2

Prostaglandin E2 is a lipid of Fatty Acyls (FA) class. Prostaglandin e2 is associated with abnormalities such as Renal glomerular disease, Arthritis, Degenerative polyarthritis, Pancreatitis and Rheumatoid Arthritis. The involved functions are known as enzyme pathway, Atherogenesis, Anabolism, inhibitors and Oxidants. Prostaglandin e2 often locates in Tissue membrane, Blood, Extracellular, Membrane and Protoplasm. The associated genes with Prostaglandin E2 are PTGS2 gene, TP53 gene, TNFRSF5 gene, FASTK Gene and TNF gene. The related lipids are Lipopolysaccharides, Steroids, monooxyethylene trimethylolpropane tristearate, Fatty Acids, Unsaturated and Promega. The related experimental models are Arthritis, Adjuvant-Induced, Xenograft Model, Experimental Autoimmune Encephalomyelitis, Cancer Model and Knock-out.

References related to functions published in Eur. J. Pharmacol.


PMIDJournalPublished DateAuthorTitle
19356723Eur. J. Pharmacol.2009Guo JY et al.Chronic treatment with celecoxib reverses chronic unpredictable stress-induced depressive-like behavior via reducing cyclooxygenase-2 expression in rat brain.
14751415Eur. J. Pharmacol.2004Warzecha Z et al.Inhibition of cyclooxygenase-2 reduces the protective effect of hepatocyte growth factor in experimental pancreatitis.
28322837Eur. J. Pharmacol.2017Kan KKW et al.Role of prostanoid EP3/1 receptors in mechanisms of emesis and defaecation in ferrets.
27565221Eur. J. Pharmacol.2016Zong M et al.Anti-cancer activity and potential mechanism of a novel aspirin derivative.
27108790Eur. J. Pharmacol.2016Rumzhum NN and Ammit AJProstaglandin E2 induces expression of MAPK phosphatase 1 (MKP-1) in airway smooth muscle cells.
27090925Eur. J. Pharmacol.2016Zhang Z et al.Anti-inflammatory activity of β-patchoulene isolated from patchouli oil in mice.
26607459Eur. J. Pharmacol.2015Root JA et al.Prostanoid receptors mediating contraction in rat, macaque and human bladder smooth muscle in vitro.
26524410Eur. J. Pharmacol.2015Wen Q et al.Des-aspartate-angiotensin I causes specific release of PGE2 and PGI2 in HUVEC via the angiotensin AT1 receptor and biased agonism.
26415983Eur. J. Pharmacol.2015Li Y et al.Regulation of PGE2 signaling pathways and TNF-alpha signaling pathways on the function of bone marrow-derived dendritic cells and the effects of CP-25.
26407653Eur. J. Pharmacol.2015Xu HB et al.Celecoxib enhanced the cytotoxic effect of cisplatin in drug-resistant human gastric cancer cells by inhibition of cyclooxygenase-2.
25614334Eur. J. Pharmacol.2015Ito M and Matsuoka IInhibition of P2Y6 receptor-mediated phospholipase C activation and Ca(2+) signalling by prostaglandin E2 in J774 murine macrophages.
24211328Eur. J. Pharmacol.2013Magnone M et al.Fluridone as a new anti-inflammatory drug.
23219793Eur. J. Pharmacol.2013Kang SH et al.Induction of inflammatory cytokines and alteration of urothelial ATP, acetylcholine and prostaglandin E2 release by doxorubicin.
22713546Eur. J. Pharmacol.2012Hsu YH et al.Long-term leptin treatment exerts a pro-apoptotic effect on renal tubular cells via prostaglandin E2 augmentation.
22575522Eur. J. Pharmacol.2012Lee JH et al.Prevention effects of ND-07, a novel drug candidate with a potent antioxidative action and anti-inflammatory action, in animal models of severe acute pancreatitis.
20832398Eur. J. Pharmacol.2010Gonzalo S et al.Intestinal effects of lipopolysaccharide in rabbit are mediated by cyclooxygenase-2 through p38 mitogen activated protein kinase.
20361960Eur. J. Pharmacol.2010Zrieki A et al.Cyclooxygenase-2 inhibitors prevent trinitrobenzene sulfonic acid-induced P-glycoprotein up-regulation in vitro and in vivo.
20353767Eur. J. Pharmacol.2010Lee J et al.Eupatolide inhibits lipopolysaccharide-induced COX-2 and iNOS expression in RAW264.7 cells by inducing proteasomal degradation of TRAF6.
18207140Eur. J. Pharmacol.2008Mrnka L et al.Melatonin inhibits prostaglandin E2- and sodium nitroprusside-induced ion secretion in rat distal colon.
17553487Eur. J. Pharmacol.2007Sidhapuriwala J et al.Effect of S-diclofenac, a novel hydrogen sulfide releasing derivative, on carrageenan-induced hindpaw oedema formation in the rat.
17316604Eur. J. Pharmacol.2007Rowland SE et al.Pharmacological characterization of a selective COX-2 inhibitor MF-tricyclic, [3-(3,4-difluorophenyl)-4-(4-(methylsulfonyl)phenyl)-2-(5H)-furanone], in multiple preclinical species.
17258197Eur. J. Pharmacol.2007Nakano M et al.Interaction between cyclooxygenase (COX)-1- and COX-2-products modulates COX-2 expression in the late phase of acute inflammation.
17125764Eur. J. Pharmacol.2007Pacheco-Sánchez M et al.Inhibitory effect of CDP, a polysaccharide extracted from the mushroom Collybia dryophila, on nitric oxide synthase expression and nitric oxide production in macrophages.
15840408Eur. J. Pharmacol.2005Takahashi HK et al.Differential effect of prostaglandins E1 and E2 on lipopolysaccharide-induced adhesion molecule expression on human monocytes.
12020690Eur. J. Pharmacol.2002Berenguer B et al.Chronic gastric ulcer healing in rats subjected to selective and non-selective cyclooxygenase-2 inhibitors.
11282124Eur. J. Pharmacol.2001Popat A and Crankshaw DJVariable responses to prostaglandin E(2) in human non-pregnant myometrium.
11166741Eur. J. Pharmacol.2001Rosenstock M et al.Prostaglandin H synthase-2 inhibitors interfere with prostaglandin H synthase-1 inhibition by nonsteroidal anti-inflammatory drugs.
11090649Eur. J. Pharmacol.2000Thapaliya S et al.Bradykinin causes endothelium-independent hyperpolarisation and neuromodulation by prostanoid synthesis in hamster mesenteric artery.
11040335Eur. J. Pharmacol.2000Lee BG et al.Suppression of inducible nitric oxide synthase expression in RAW 264. 7 macrophages by two beta-carboline alkaloids extracted from Melia azedarach.
10729362Eur. J. Pharmacol.2000Koyama A et al.Nitric oxide accelerates the ascorbic acid-induced osteoblastic differentiation of mouse stromal ST2 cells by stimulating the production of prostaglandin E(2).
10666512Eur. J. Pharmacol.2000Shimada K et al.The effect of endothelin-1 on lipopolysaccharide-induced cyclooxygenase 2 expression in association with prostaglandin E(2).
10594346Eur. J. Pharmacol.1999Yamada R et al.Auranofin inhibits interleukin-1beta-induced transcript of cyclooxygenase-2 on cultured human synoviocytes.
10422646Eur. J. Pharmacol.1999Marquet F et al.Distant intestinal stimulation by cholera toxin in rat in vivo.
10323281Eur. J. Pharmacol.1999Sánchez T and Moreno JJKetoprofen S(+) enantiomer inhibits prostaglandin production and cell growth in 3T6 fibroblast cultures.
9671112Eur. J. Pharmacol.1998Zamora R et al.The role of prostaglandin E2 and nitric oxide in cell death in J774 murine macrophages.
9600662Eur. J. Pharmacol.1998Niki H et al.Effects of JTE-522, a specific inhibitor of cyclooxygenase-2, on the recurrence of allergic inflammation in rats.
9544793Eur. J. Pharmacol.1998Konturek PC et al.Activation of genes for growth factors and cyclooxygenases in rat gastric mucosa during recovery from stress damage.